Ocular drug delivery systems: An overview

doi:10.5497/wjp.v2.i2.47

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (31658)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

2262

HTML

26344

Figures (1-7)

349

Tables (1-2)

334

Sum=29289

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1342

Download

1027

Sum=2369

Jun 9, 2013 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (608)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Pharmacol. Jun 9, 2013; 2(2): 47-64
Published online Jun 9, 2013. doi: 10.5497/wjp.v2.i2.47

Full Size Figure Download Figure

Figure 7 Acyclovir concentrations in aqueous humor after topical administration of Acyclovir solution and Acyclovir-containing liposomes. ^aP < 0.05 vs positively charged liposomes (n = 6). Reproduced with permission from reference Law et al[83]. ACV: Acyclovir.

Citation: Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: An overview. World J Pharmacol 2013; 2(2): 47-64
URL: https://www.wjgnet.com/2220-3192/full/v2/i2/47.htm
DOI: https://dx.doi.org/10.5497/wjp.v2.i2.47